Bluebird bio
Integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing. Learn more
Launch date
Employees
Market cap
AUD166m
Enterprise valuation
AUD361m (Public information from Sep 2024)
Share price
$0.56 BLUE.MX
Cambridge Massachusetts (HQ)
Authorizing premium user...